All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Colorectal cancer (CRC) in Spain, with an estimated 16071 new cases in 2014 \[[@pone.0164620.ref001]\], represents the second most common tumor in women and the second leading cause of death, accounting for 15.3% of all female cancer-related deaths in 2013 \[[@pone.0164620.ref002]\]. In Spain, as in other developed countries \[[@pone.0164620.ref003]\], there has been an increase in incidence due to this type of cancer, slightly attenuated around 1995 \[[@pone.0164620.ref004]\]. However, mortality rates have reached a plateau since the beginning of this century \[[@pone.0164620.ref005]\].

Gastric cancer (GC) in Spanish women occupies the tenth position in incidence, with an adjusted rate of 7.5 cases per 100,000 estimated for 2012 \[[@pone.0164620.ref006]\]. In terms of mortality, the rate estimated for this same year was 4.8 per 100,000, accounting for 5.3% of all female cancer-related deaths in 2013 \[[@pone.0164620.ref002]\]. The small difference between the incidence and mortality rates is due to the low survival recorded for this tumor, which is estimated in Spain to be 26.0% at 5 years \[[@pone.0164620.ref001]\].

Hormonal factors may play a role in the etiology of both tumors: incidence is approximately twofold higher among males than among females \[[@pone.0164620.ref006]\], even though differential exposure to established risk factors cannot totally explain these differences. On the other hand, it has been suggested that estrogens may offer protection against the development of both tumors, and this protective effect seems to be modulated through estrogen receptors (ER) identified in non-cancerous and cancerous gastric \[[@pone.0164620.ref007]\] and colonic tissue \[[@pone.0164620.ref008], [@pone.0164620.ref009]\]. Recent studies indicate that the protection conferred to CRC risk could be limited to certain molecular tumor subtypes \[[@pone.0164620.ref008]\] and to exogenous estrogens exposure \[[@pone.0164620.ref009], [@pone.0164620.ref010]\]. On the contrary, while some studies have observed lower GC risk associated with the exposure to estrogens of both ovarian and exogenous origin \[[@pone.0164620.ref011]\], other authors have detected this association with endogenous estrogen exposure only \[[@pone.0164620.ref012]\].

The role of menstrual and reproductive factors in the etiology of GC, and mainly CRC, has drawn interest in the literature, but findings are not consistent, especially in the case of GC where most studies have been limited by small number of cases. This study sought to investigate the influence of menstrual and reproductive factors on female GC and CRC risk in a large population-based case control study in Spain. We also assessed if these associations differ by specific CRC subsite. Finally, taking into account that reproductive patterns and the use of hormonal compounds are strongly influenced by womens' educational level \[[@pone.0164620.ref013]\] and that highly educated women tend to have healthier life-styles \[[@pone.0164620.ref014], [@pone.0164620.ref015]\], we evaluated the influence of reproductive factors separately in women with high and low educational background.

Materials and Methods {#sec006}
=====================

Study population {#sec007}
----------------

Multicase-control Spain study (MCC-Spain, [www.mccspain.org](http://www.mccspain.org/)) \[[@pone.0164620.ref016]\], with population controls and incident cases was carried out between September 2008 and December 2013 to investigate the influence of environmental factors and their interaction with genetic factors in highly prevalent tumors or with peculiar epidemiological characteristics in Spain. Cases of breast, prostate, gastric, colorectal tumors and chronic lymphocytic leukemias were recruited from 23 hospitals in 12 Spanish provinces. Inclusion criteria required that participants should have resided for at least 6 months in the study areas, had to be aged 20--85 and had to be mentally qualified to answer the questionnaire. A group of controls, common for the five types of tumors, was randomly selected from the administrative records of a number of primary care health centers within the catchment areas of the hospitals where cases were recruited. We made an initial estimate of the age-sex distribution that cases--all combined- would have in each region, according to the tumors they recruited and to the cancer incidence rates from Spanish cancer registries. We applied these estimates to predefine the age-sex distribution of our population-based controls, which were selected randomly from the general practitioner lists of each hospital catchment area. When the recruitment of cases ended, we compared again the age- sex- distribution of cases and controls and recruited new participants if needed in an attempt to ensure that each case had at least one control of the same 5-year age interval and sex in each region. Controls were initially contacted via telephone and those who agreed to participate in the study were scheduled for a personal interview. Cases of GC were recruited in Madrid, Barcelona, León, Navarra, Cantabria, Asturias, Huelva, Valencia and Granada. CRC cases were also recruited in Guipúzcoa and Murcia. Our research personnel actively searched for new cases, through regular visits to the collaborating hospital departments (gastroenterology, oncology, general surgery, radiotherapy and pathology) and reviewed the hospital admission registries weekly.

For the present study we recruited a total of 151 histologically-confirmed female GC cases (codes C16:*Malignant neoplasm of stomach* and D00.2:*Carcinoma in situ of stomach*, according to the 10th revision of the International Statistical Classification of Diseases), and 775 female CRC cases (codes C18:*Malignant neoplasm of colon*, C19:*Malignant neoplasm of rectosigmoid junction*, C20:*Malignant neoplasm of rectum*, D01.0:C*arcinoma in situ of colon*, D01.1:C*arcinoma in situ of rectosigmoid junction* and D01.2:*Carcinoma in situ of rectum*) with no prior history of the disease and diagnosed within the recruitment period. Those controls with a history of GC or CRC were excluded, as well as those who resided in provinces that had not recruited these tumors and those that were more than five years younger than the youngest case included in each region. A total of 1548 and 1932 female controls were included for the GC and CRC analyses, respectively. Flow charts displaying the selection process of CRC cases and controls and GC cases and control are shown in [Fig 1](#pone.0164620.g001){ref-type="fig"} and [Fig 2](#pone.0164620.g002){ref-type="fig"} respectively.

![Flow chart displaying the selection process of colorectal cancer cases and controls.\
MCC-Spain study 2008--2013.](pone.0164620.g001){#pone.0164620.g001}

![Flow chart displaying the selection process of gastric cancer cases and controls.\
MCC-Spain study 2008--2013.](pone.0164620.g002){#pone.0164620.g002}

Ethical approval {#sec008}
----------------

The protocol of MCC-Spain was approved by Ethics Committees of the participating institutions: Comité Ético de Investigación Clínica (CEIC) del Instituto Municipal de Asistencia Sanitaria de Barcelona; CEIC del Hospital Universitario de Bellvitge; CEIC de Navarra; CEIC del Hospital Universitario La Paz; CEIC del Hospital Universitario Ramón y Cajal; CEIC de Cantabria; CEIC de la Dirección General de Salud Pública y Centro Superior de Investigación en Salud Pública; CEIC del Hospital General Universitario Jose Mª Morales Meseguer; Comité de Ética de la Investigación de la Provincia de Huelva; CEIC de León; Comité Ético de Investigación del Principado de Asturias; Comité de Ética de la Investigación Biomédica Provincial de Granada; Comité de Ética en Investigación Humana de la Universidad de Granada; Comité Ético de Investigación de la Comunidad Autónoma del País Vasco. All participants were informed about the study objectives and signed an informed consent. Confidentiality of data is secured removing personal identifiers in the datasets. The database was registered in the Spanish Agency for Data Protection, number 2102672171.

Data collection {#sec009}
---------------

Exposure information was collected by trained interviewers through face-to-face interviews using a structured electronic questionnaire, including detailed information on demographic factors, occupation, personal and family history, lifestyle and diet \[[@pone.0164620.ref017]\]. Menstrual factors gathered by the questionnaire included age at menarche, regularity of the menstrual cycle, menopausal status, age and cause of menopause, use of hormonal contraceptives and hormone replacement therapy. Regarding reproductive history, the questionnaire collected information on fertility problems and their treatment, number of miscarriages, number of children, newborns\' sex, year of birth, gestational age and duration of maternal lactation.

Statistical analyses {#sec010}
--------------------

Descriptive analyses of participants' characteristics were done for GC, colon cancer (CC) and rectal cancer (RC) cases and controls. We used absolute figures and percentages to describe categorical variables, and means and standard deviations to describe continuous variables. Significant differences between cases and controls were tested using Pearson chi-square and Student\'s t-test for categorical and continuous variables respectively.

The association of menstrual and reproductive variables with GC, CC and RC was assessed using logistic mixed regression models, including the province as a random effect term to account for unexplained heterogeneity associated with province, such as distribution of unmeasured potential risk factors or differences between interviewers. Models were adjusted for age, educational level, body mass index (BMI) one year prior to the interview, tobacco consumption, family history of the studied cancer, hormone replacement therapy use and hormonal contraception use. We also conducted an additional analysis in CRC cases and controls stratifying by educational level, not done for GC due to the low number of cases. Finally, a sensitivity analysis was done additionally adjusting for calorie intake, red meat, processed meat, fruits, vegetables and alcohol consumption in those participants who fulfilled the food frequency questionnaire (Supporting Information).

CRC patients were classified according to tumor subsite: CC and RC (two cases were of unspecified subsite). Since our response variable has three categories (0 = controls, 1 = CC cases and 2 = RC cases), we fitted multinomial logistic regression models to evaluate the association of menstrual and reproductive factors with the above-mentioned CRC subsites. These models were adjusted by the same set of variables described above, including the province as a random effect term. Heterogeneity of effects was tested using a Wald test to compare the coefficients obtained for the different CRC subsites. Data were analyzed using STATA/MP 13.1 software.

Results {#sec011}
=======

Response rates were 53.8% for healthy female controls, 62.1% for female CRC cases and 55.7% for female GC cases. Results presented in this manuscript are based on women with no missing values in any of the selected confounders (73% of CRC cases, 85% of GC cases and 83% of controls). We included 562 CRC cases (364 colon cases and 196 rectal cases) and 1605 controls, as well as 128 GC cases and 1293 controls. [Table 1](#pone.0164620.t001){ref-type="table"} shows the main characteristics of these women. In general, gastric, colon and rectal cases were older and had higher BMI than controls. They also smoked less, had lower educational level, had a delayed menarche, had more children, had their first child at a younger age, had longer breastfeeding periods and reported to use less hormone replacement therapy and hormonal contraception than controls.

10.1371/journal.pone.0164620.t001

###### Socio-demographic, menstrual and reproductive characteristics in gastric and colorectal cancer cases and controls.

![](pone.0164620.t001){#pone.0164620.t001g}

                                                                                   GASTRIC CANCER   COLORECTAL CANCER                                                                                           
  ------------------------------------------ ------------------------------------- ---------------- ------------------- -------- --------- ------ -------- ------- -------- --------- ------ -------- --------- --
  Age, mean(SD)                              59.5                                  (12.6)           65.0                (14.2)   \<0.001   58.9   (12.5)   65.5    (11.4)   \<0.001   64.3   (11.8)   \<0.001   
  Educational level                                                                                                              \<0.001                                    \<0.001                   \<0.001   
                                             Less than primary school              197              (15%)               52       (41%)            259      (16%)   108      (30%)            65       (33%)     
                                             Primary school completed              422              (33%)               47       (37%)            490      (31%)   140      (38%)            74       (38%)     
                                             Secondary school                      392              (30%)               24       (19%)            495      (31%)   73       (20%)            35       (18%)     
                                             University graduate                   282              (22%)               5        (4%)             361      (22%)   43       (12%)            22       (11%)     
  BMI                                                                                                                            0.003                                      \<0.001                   0.045     
                                             \<20 Kg/m^2^                          91               (7%)                5        (4%)             111      (7%)    15       (4%)             13       (7%)      
                                             20--24 Kg/m^2^                        542              (42%)               36       (28%)            681      (42%)   116      (32%)            64       (33%)     
                                             25--29 Kg/m^2^                        409              (32%)               50       (39%)            506      (32%)   139      (38%)            78       (40%)     
                                             \>29 Kg/m^2^                          251              (19%)               37       (29%)            307      (19%)   94       (26%)            41       (21%)     
  Smoking                                                                                                                        0.001                                      \<0.001                   0.004     
                                             Never smoker                          778              (60%)               97       (76%)            934      (58%)   257      (71%)            135      (69%)     
                                             Former smoker \> 1.5 years            257              (20%)               10       (8%)             332      (21%)   56       (15%)            38       (19%)     
                                             Smoker or former smoker \<1.5 years   258              (20%)               21       (16%)            339      (21%)   51       (14%)            23       (12%)     
  Family history colorectal/gastric cancer                                                                                       \<0.001                                    \<0.001                   0.005     
                                             None                                  1160             (90%)               90       (70%)            1397     (87%)   283      (78%)            160      (82%)     
                                             Second degree only                    77               (6%)                9        (7%)             67       (4%)    15       (4%)             7        (4%)      
                                             1 first degree                        53               (4%)                20       (16%)            129      (8%)    55       (15%)            23       (12%)     
                                             \>1 first degree                      3                (0%)                9        (7%)             12       (1%)    11       (3%)             6        (3%)      
  Age at menarche, mean(SD)                  12.8                                  (1.7)            13.2                (2.0)    0.018     12.8   (1.6)    13.0    (1.7)    0.024     13.2   (1.6)    0.006     
  Number of children                                                                                                             0.006                                      0.001                     0.047     
                                             None                                  235              (18%)               22       (17%)            278      (17%)   43       (12%)            27       (14%)     
                                             1--2                                  716              (55%)               55       (43%)            902      (56%)   190      (52%)            99       (51%)     
                                             3--4                                  279              (22%)               39       (30%)            350      (22%)   103      (28%)            58       (30%)     
                                             \>4                                   61               (5%)                12       (9%)             72       (4%)    28       (8%)             12       (6%)      
  Age at first birth, mean(SD)               26.7                                  (4.8)            24.8                (4.7)    \<0.001   26.8   (4.8)    26.2    (4.5)    0.040     26     (5.2)    0.051     
  Lactation first child (months), mean(SD)   4.5                                   (5.7)            5.5                 (5.8)    0.113     4.4    (5.6)    5.4     (6.1)    0.008     5.6    (6.1)    0.020     
  History of miscarriages                                                                                                        0.768                                      0.013                     0.597     
                                             None                                  985              (76%)               99       (77%)            1231     (77%)   301      (83%)            147      (75%)     
                                             One or more                           308              (24%)               29       (23%)            374      (23%)   63       (17%)            49       (25%)     
  Menopausal status                                                                                                              0.001                                      \<0.001                   \<0.001   
                                             Premenopausal                         340              (26%)               17       (13%)            456      (28%)   39       (11%)            29       (15%)     
                                             Posmenopausal                         953              (74%)               111      (87%)            1149     (72%)   325      (89%)            167      (85%)     
  Hormonal contraception use                                                                                                     \<0.001                                    \<0.001                   \<0.001   
                                             Never                                 668              (52%)               101      (79%)            809      (50%)   254      (70%)            135      (69%)     
                                             Ever                                  625              (48%)               27       (21%)            796      (50%)   110      (30%)            61       (31%)     
  Postmenopausal women                                                                                                                                                                                          
    Hormone therapy use                                                                                                          0.121                                      \<0.001                   0.016     
                                             Never                                 858              (90%)               105      (95%)            1025     (89%)   311      (96%)            159      (95%)     
                                             Ever                                  95               (10%)               6        (5%)             124      (11%)   14       (4%)             8        (5%)      
    Age at menopause, mean(SD)               48.4                                  (5.3)            47.9                (5.6)    0.397     48.6   (5.3)    48.7    (5.2)    0.667     48.7   (5.0)    0.663     
    Fertility time (years), mean(SD)         35.5                                  (5.4)            34.7                (5.7)    0.183     35.7   (5.4)    35.7    (5.2)    0.949     35.5   (4.9)    0.638     

[Table 2](#pone.0164620.t002){ref-type="table"} shows the association between GC, CC and RC risk and menstrual and reproductive factors. Age at first birth displayed an inverse association with GC, decreasing the risk by 31% for every five years increase in age at first birth (P = 0.006) (\>29 years vs. \<25: OR = 0.52; 95%CI = 0.28--0.97). This result remained significant even after adjustment for number of children (five-year trend: OR = 0.71; P = 0.014) or additionally adjusting for calorie intake, red meat, processed meat, fruits, vegetables and alcohol consumption (five-year trend: OR = 0.71; P = 0.046) ([S1 Table](#pone.0164620.s001){ref-type="supplementary-material"}). Women who ever used hormonal contraception showed a decreased gastric (OR = 0.42; 95%CI = 0.26--0.69), colon (OR = 0.64; 95%CI = 0.48--0.86), and rectal (OR = 0.61; 95%CI = 0.43--0.88) cancer risk, results that are confirmed after adjustment for calorie intake, red meat, processed meat, fruits, vegetables and alcohol consumption. The protection conferred by hormonal contraception use was stronger for those who used it more than 5 years for all cancer types (OR for GC = 0.26; 95%CI = 0.10--0.67; OR for CC = 0.59; 95%CI = 0.38--0.92; OR for RC = 0.53; 95%CI = 0.30--0.95). Finally, postmenopausal women who ever used hormone replacement therapy showed a decreased CC risk (OR = 0.44; 95%CI = 0.24--0.78) and almost significant decreased RC risk (OR = 0.51; 95%CI = 0.24--1.07). No significant differences were detected between colon and rectal tumors in any of the variables analyzed. Also, no significant associations were observed between GC, CC and RC risk and other menstrual and reproductive variables (history of miscarriages, age at menopause, fertility time, fertility time without children, time since last child, time since menopause, and each woman\'s cumulative lifetime lactation) (data not shown).

10.1371/journal.pone.0164620.t002

###### Association between menstrual and reproductive characteristics and gastric and colorectal cancer risk.

![](pone.0164620.t002){#pone.0164620.t002g}

                                                                                                  GASTRIC CANCER   COLORECTAL CANCER                                                                                                                                                                         
  ---------------------------- ------------------------------------------------------------ ----- ---------------- ------------------- ---------- ------ ---------- ----------- ------ ------ ---------- ---------- ------ ---------- ----------- ------ ---------- ---------- ------ ---------- ----------- -------
  Premenopausal status         340                                                          17    0.94             0.45                \-         2.00   0.882      456         39     0.65   0.41       \-         1.03   0.068      29          0.82   0.47       \-         1.45   0.500      0.494       
  Nulliparity                  235                                                          22    1.12             0.65                \-         1.92   0.682      278         43     0.78   0.53       \-         1.13   0.184      27          0.95   0.60       \-         1.50   0.824      0.464       
  Parous women                                                                                                                                                                                                                                                                                               
                               Age at first birth (years)                                                                                                                                                                                                                                                    
                                   \<25                                                     369   58               1.00                                                         437    126    1.00                                                80     1.00                                                
                                   25--29                                                   409   31               0.52                0.32       \-     0.86       0.010       533    129    0.84       0.63       \-     1.13       0.242       58     0.62       0.43       \-     0.90       0.013       
                                   \>29                                                     273   16               0.52                0.28       \-     0.97       0.040       346    64     0.79       0.55       \-     1.14       0.207       30     0.63       0.39       \-     1.00       0.052       
                               *    Five-year trend*[\*](#t002fn004){ref-type="table-fn"}                          *0*.*69*            *0*.*53*   *-*    *0*.*90*   *0*.*006*                 *0*.*95*   *0*.*82*          *1*.*10*   *0*.*473*          *0*.*95*   *0*.*78*          *1*.*14*   *0*.*556*   0.978
                               No. of children                                                                                                                                                                                                                                                               
                                   1--2                                                     716   55               1.00                                                         902    190    1.00                                                99     1.00                                                
                                   3--4                                                     279   39               1.27                0.78       \-     2.04       0.337       350    103    0.96       0.72       \-     1.29       0.810       58     1.11       0.77       \-     1.62       0.574       
                                   \> 4                                                     61    12               1.77                0.82       \-     3.82       0.144       72     28     1.09       0.66       \-     1.80       0.743       12     0.99       0.50       \-     1.96       0.977       
                               *    Trend per child*[\*](#t002fn004){ref-type="table-fn"}                          *1*.*13*            *0*.*96*   *-*    *1*.*33*   *0*.*145*                 *1*.*04*   *0*.*94*          *1*.*15*   *0*.*454*          *0*.*97*   *0*.*85*          *1*.*11*   *0*.*703*   0.394
                               Lactation first child (months)                                                                                                                                                                                                                                                
                                   None                                                     185   23               1.40                0.80       \-     2.48       0.241       241    58     1.04       0.72       \-     1.48       0.841       34     1.29       0.82       \-     2.02       0.274       
                                   1--6                                                     542   43               1.00                                                         682    141    1.00                                                67     1.00                                                
                                   \>6                                                      177   28               1.53                0.89       \-     2.65       0.126       217    80     1.26       0.89       \-     1.77       0.192       44     1.43       0.93       \-     2.21       0.105       
                               *    Six-month trend*[\*](#t002fn004){ref-type="table-fn"}                          *1*.*10*            *0*.*89*   *-*    *1*.*35*   *0*.*385*                 *1*.*10*   *0*.*95*          *1*.*26*   *0*.*199*          *1*.*09*   *0*.*92*          *1*.*30*   *0*.*294*   0.987
  No. of miscarriages                                                                                                                                                                                                                                                                                        
                               None                                                         985   99               1.00                                                         1231   301    1.00                                                147    1.00                                                
                               One or more                                                  308   29               1.21                0.76       \-     1.93       0.416       374    63     0.75       0.55       \-     1.03       0.073       49     1.23       0.86       \-     1.76       0.246       0.089
  Age at menarche (years)                                                                                                                                                                                                                                                                                    
                               \<12                                                         254   24               1.25                0.72       \-     2.16       0.430       320    70     1.15       0.83       \-     1.61       0.400       33     0.94       0.61       \-     1.46       0.791       
                               12--13                                                       599   46               1.00                                                         749    144    1.00                                                82     1.00                                                
                               \>13                                                         433   56               1.26                0.81       \-     1.96       0.298       523    146    1.17       0.89       \-     1.53       0.267       80     1.15       0.81       \-     1.61       0.438       
                               *Trend per year*[\*](#t002fn004){ref-type="table-fn"}                               *1*.*05*            *0*.*94*   *-*    *1*.*17*   *0*.*397*                 *1*.*01*   *0*.*94*          *1*.*09*   *0*.*713*          *1*.*07*   *0*.*97*   *-*    *1*.*17*   *0*.*155*   0.319
  Hormonal contraception use                                                                                                                                                                                                                                                                                 
                               Never                                                        668   101              1.00                                                         809    254    1.00                                                135    1.00                                                
                               Ever                                                         625   27               0.42                0.26       \-     0.69       0.001       796    110    0.64       0.48       \-     0.86       0.003       61     0.61       0.43       \-     0.88       0.009       0.820
                                   \< = 5 years                                             255   16               0.62                0.34       \-     1.13       0.121       315    47     0.69       0.48       \-     1.00       0.052       27     0.68       0.42       \-     1.09       0.108       
                                   \>5 years                                                191   5                0.26                0.10       \-     0.67       0.006       249    30     0.59       0.38       \-     0.92       0.020       16     0.53       0.30       \-     0.95       0.034       
                                   Not known                                                179   6                0.31                0.13       \-     0.75       0.009       232    33     0.63       0.41       \-     0.97       0.036       18     0.60       0.35       \-     1.04       0.069       
  Postmenopausal women                                                                                                                                                                                                                                                                                       
    Age at menopause (years)                                                                                                                                                                                                                                                                                 
                                   \< = 45                                                  208   17               0.68                0.35       \-     1.33       0.260       245    57     0.81       0.55       \-     1.19       0.283       40     1.15       0.72       \-     1.84       0.567       
                                   46--49                                                   226   31               1.07                0.60       \-     1.92       0.821       259    78     1.02       0.71       \-     1.47       0.902       32     0.87       0.53       \-     1.44       0.595       
                                   50--52                                                   238   31               1.00                                                         294    90     1.00                                                45     1.00                                                
                                   \>52                                                     167   15               0.70                0.36       \-     1.39       0.312       212    64     0.92       0.63       \-     1.34       0.661       29     0.83       0.50       \-     1.38       0.464       
                               *Five-year trend*[\*](#t002fn004){ref-type="table-fn"}                              *0*.*92*            *0*.*75*   *-*    *1*.*14*   *0*.*451*                 *1*.*00*   *0*.*87*   *-*    *1*.*13*   *0*.*947*          *0*.*99*   *0*.*83*   *-*    *1*.*18*   *0*.*910*   0.955
    Fertility time (years)                                                                                                                                                                                                                                                                                   
                                   \<33                                                     202   28               1.00                                                         236    73     1.00                                                36     1.00                                                
                                   33--36                                                   233   23               0.75                0.40       \-     1.41       0.371       269    82     0.98       0.67       \-     1.43       0.916       46     1.09       0.68       \-     1.77       0.715       
                                   37--39                                                   213   22               0.75                0.40       \-     1.43       0.386       263    69     0.83       0.56       \-     1.22       0.340       33     0.79       0.47       \-     1.32       0.366       
                                   \>39                                                     185   19               0.82                0.43       \-     1.59       0.565       233    64     0.82       0.55       \-     1.23       0.340       30     0.77       0.45       \-     1.31       0.333       
                               *    Five-year trend*[\*](#t002fn004){ref-type="table-fn"}                          *0*.*91*            *0*.*75*   *-*    *1*.*12*   *0*.*379*                 *0*.*99*   *0*.*87*   *-*    *1*.*12*   *0*.*871*          *0*.*94*   *0*.*80*   *-*    *1*.*11*   *0*.*463*   0.588
    Hormone therapy use                                                                                                                                                                                                                                                                                      
                               Never                                                        858   105              1.00                                                         1025   311    1.00                                                159    1.00                                                
                               Ever                                                         95    6                0.63                0.26       \-     1.53       0.306       124    14     0.44       0.24       \-     0.78       0.005       8      0.51       0.24       \-     1.07       0.075       0.743

^a^ Totals do not add up because of missing values.

^b^ Odds ratios (ORs) and 95% confidence intervals (95% CI) adjusted for age, educational level, BMI 1-year prior to the interview, family history of gastric/colorectal cancer, tobacco, hormone therapy use and hormonal contraception use (the latter two variables were excluded as confounders when analyzing their association with gastric and colorectal cancer risk). Province was included as a random effect term.

^c^ P-int.: P value of the interaction term between tumor subsite and the corresponding variable.

\* In italics: ORs, 95% CI and P values obtained with the corresponding variable as a continuous term.

[Table 3](#pone.0164620.t003){ref-type="table"} presents the results of these associations with CRC risk stratified by educational background. Number of children and months of lactation displayed different effects in women with low and high educational level, with the interaction term proving statistically significant (P = 0.001 and 0.040 respectively): while parity showed a positive trend among women with low educational level (primary school or less), in women with higher level of education (secondary school or university) the OR decreased by 23% for every child (P = 0.012). With respect to months of lactation, whereas those women with lower educational background who breastfed their first child for longer periods registered an increased CRC risk (\>6 months vs. 1--6 months: OR = 1.55; 95%CI = 1.10--2.18; P trend = 0.031), those with higher education, showed the opposite effect, although this association was not statistically significant, probably due to the small number of cases who breastfed more than six months. The protection conferred by hormonal contraception and hormone replacement therapy use was in evidence in both groups, although it was stronger for women with low educational level. While duration of hormonal contraception use was not associated with CRC risk in women with low educational level, in those with higher educational background the risk decreased by 28% for every 5-year increase in hormonal contraception use (P = 0.032) (data not shown). Finally we also detected a U-shape association with age at menarche among women with higher educational level (\<12 years vs. 12--13: OR = 1.51; 95%CI = 0.98--2.33; \>13 years vs. 12--13: OR = 1.57; 95%CI = 1.06--2.34). These analyses were repeated additionally adjusting for the above mentioned dietary variables, but this led to no change in the results ([S2 Table](#pone.0164620.s002){ref-type="supplementary-material"}).

10.1371/journal.pone.0164620.t003

###### Association between menstrual and reproductive characteristics and colorectal cancer risk by educational level.

![](pone.0164620.t003){#pone.0164620.t003g}

                                                                                            COLORECTAL CANCER                                                                                                                               
  ---------------------------- ------------------------------------------------------------ ------------------- ------ ---------- ---------- ------ ---------- ----------- ----- ------ ---------- ---------- ------ ---------- ----------- -------
  Premenopausal status         99                                                           27                  0.86   0.51       \-         1.46   0.575      357         42    0.65   0.42       \-         1.01   0.054      0.360       
  Nulliparity                  70                                                           29                  0.71   0.44       \-         1.15   0.167      208         42    0.95   0.64       \-         1.41   0.798      0.366       
  Parous women                                                                                                                                                                                                                              
                               Age at first birth (years)                                                                                                                                                                                   
                                   \<25                                                     277                 164    1.00                                                160   42     1.00                                                
                                   25--29                                                   276                 136    0.77       0.57       \-     1.04       0.091       257   52     0.72       0.45       \-     1.15       0.168       
                                   \>29                                                     117                 57     0.75       0.51       \-     1.11       0.152       229   37     0.68       0.41       \-     1.13       0.138       
                               *    Five-year trend*[\*](#t003fn004){ref-type="table-fn"}                              *0*.*97*   *0*.*83*   *-*    *1*.*13*   *0*.*671*                *0*.*91*   *0*.*74*   *-*    *1*.*11*   *0*.*353*   0.629
                               No. of children                                                                                                                                                                                              
                                   1--2                                                     420                 184    1.00                                                482   106    1.00                                                
                                   3--4                                                     212                 139    1.27       0.94       \-     1.70       0.116       138   22     0.54       0.32       \-     0.90       0.019       
                                   \> 4                                                     46                  35     1.33       0.81       \-     2.20       0.262       26    5      0.49       0.18       \-     1.38       0.180       
                               *    Trend per child*[\*](#t003fn004){ref-type="table-fn"}                              *1*.*10*   *0*.*99*   *-*    *1*.*21*   *0*.*072*                *0*.*77*   *0*.*63*   *-*    *0*.*94*   *0*.*012*   0.001
                               Lactation first child (months)                                                                                                                                                                               
                                   None                                                     137                 65     1.12       0.77       \-     1.63       0.548       104   27     1.13       0.68       \-     1.88       0.646       
                                   1--6                                                     323                 134    1.00                                                359   75     1.00                                                
                                   \>6                                                      139                 112    1.55       1.10       \-     2.18       0.012       78    12     0.68       0.35       \-     1.34       0.266       
                               *    Six-month trend*[\*](#t003fn004){ref-type="table-fn"}                              *1*.*17*   *1*.*01*   *-*    *1*.*34*   *0*.*031*                *0*.*82*   *0*.*59*   *-*    *1*.*15*   *0*.*249*   0.040
  No. of miscarriages                                                                                                                                                                                                                       
                               None                                                         584                 317    1.00                                                647   132    1.00                                                
                               One or more                                                  165                 70     0.81       0.59       \-     1.13       0.212       209   43     1.09       0.74       \-     1.62       0.657       0.686
  Age at menarche (years)                                                                                                                                                                                                                   
                               \<12                                                         134                 58     0.84       0.57       \-     1.22       0.353       186   45     1.51       0.98       \-     2.33       0.059       
                               12--13                                                       317                 161    1.00                                                432   66     1.00                                                
                               \>13                                                         289                 166    0.99       0.75       \-     1.32       0.972       234   61     1.57       1.06       \-     2.34       0.026       
                               *Trend per year*[\*](#t003fn004){ref-type="table-fn"}                                   *1*.*03*   *0*.*96*   *-*    *1*.*11*   *0*.*430*                *1*.*04*   *0*.*94*   *-*    *1*.*16*   *0*.*444*   0.861
  Hormonal contraception use                                                                                                                                                                                                                
                               Never                                                        475                 305    1.00                                                334   85     1.00                                                
                               Ever                                                         274                 82     0.55       0.40       \-     0.75       \<0.001     522   90     0.75       0.53       \-     1.06       0.099       0.179
                                   \< = 5 years                                             105                 34     0.59       0.38       \-     0.92       0.019       210   41     0.82       0.53       \-     1.26       0.368       
                                   \>5 years                                                78                  25     0.66       0.40       \-     1.10       0.111       171   21     0.51       0.30       \-     0.87       0.014       
                                   Not known                                                91                  23     0.42       0.25       \-     0.70       0.001       141   28     0.94       0.57       \-     1.55       0.806       
  Postmenopausal women                                                                                                                                                                                                                      
    Age at menopause (years)                                                                                                                                                                                                                
                                   \< = 45                                                  142                 64     0.80       0.54       \-     1.20       0.283       103   33     1.22       0.69       \-     2.15       0.494       
                                   46--49                                                   143                 79     0.95       0.65       \-     1.39       0.787       116   31     1.07       0.60       \-     1.90       0.815       
                                   50--52                                                   164                 102    1.00                                                130   33     1.00                                                
                                   \>52                                                     138                 74     0.88       0.60       \-     1.30       0.528       74    20     0.91       0.48       \-     1.73       0.774       
                               *Five-year trend*[\*](#t003fn004){ref-type="table-fn"}                                  *1*.*05*   *0*.*92*   *-*    *1*.*21*   *0*.*465*                *0*.*87*   *0*.*71*   *-*    *1*.*06*   *0*.*161*   0.114
    Fertility time (years)                                                                                                                                                                                                                  
                                   \<33                                                     137                 79     1.00                                                99    30     1.00                                                
                                   33--36                                                   162                 93     1.00       0.67       \-     1.48       0.992       107   35     1.04       0.58       \-     1.85       0.904       
                                   37--39                                                   144                 74     0.85       0.56       \-     1.28       0.428       119   28     0.74       0.40       \-     1.34       0.317       
                                   \>39                                                     138                 72     0.86       0.57       \-     1.30       0.477       95    23     0.68       0.36       \-     1.28       0.231       
                               *    Five-year trend*[\*](#t003fn004){ref-type="table-fn"}                              *1*.*02*   *0*.*89*   *-*    *1*.*16*   *0*.*774*                *0*.*87*   *0*.*71*   *-*    *1*.*06*   *0*.*168*   0.189
    Hormone therapy use                                                                                                                                                                                                                     
                               Never                                                        585                 350    1.00                                                440   121    1.00                                                
                               Ever                                                         65                  10     0.30       0.15       \-     0.60       0.001       59    12     0.74       0.38       \-     1.47       0.393       0.064

^a^ Totals do not add up because of missing values.

^b^ Odds ratios (ORs) and 95% confidence intervals (95% CI) adjusted for age, BMI 1-year prior to the interview, family history of colorectal cancer, tobacco, hormone therapy use and hormonal contraception use (the latter two variables were excluded as confounders when analyzing their association with colorectal cancer risk). Province was included as a random effect term.

^c^ P-int.: P value of the interaction term between educational level and the corresponding variable.

\* In italics: ORs, 95% CI and P values obtained with the corresponding variable as a continuous term.

Discussion {#sec012}
==========

This case-control study with population controls examines the association between recalled menstrual and reproductive factors and GC and CRC risk, and evaluates whether the effect differ by educational level. Our results show a decreased GC risk associated with older age at first birth; a decreased GC, CC and RC risk associated with ever use of hormonal contraception and a decreased CC and RC risk among postmenopausal hormone therapy users. Women with low educational level who had more children or who breastfed their first child for longer periods registered an increased CRC risk, while those with higher educational background showed the opposite effect.

One of the main strengths of this study is its large sample size, since to date it is the largest epidemiological study that analyses the association between GC and CRC risk and menstrual and reproductive factors in the Spanish population. The study was carried out in 11 Spanish provinces, covering rural and urban areas. In addition, we have used histologically confirmed incident cases and population-based controls. Finally, the random province-specific intercept term included in our statistical models allowed us to take into account unexplained heterogeneity due to unmeasured factors across different provinces.

Some limitations should also be considered. First, self-reported information is subjected to recall bias. However, if this bias exists, it would probably be non-differential, since the possible association between reproductive factors and GC and CRC risk is largely unknown. Several previous studies have concluded that self-reported information of age at menopause, age at menarche, number of children, age at first pregnancy, age at first and last birth and spontaneous abortions are recalled with reasonable accuracy \[[@pone.0164620.ref018], [@pone.0164620.ref019]\]. These same variables were used in a previous study of our group that analyzed the influence of obstetric factors on mammographic density in adult Spanish women \[[@pone.0164620.ref020]\]. In a quality control analysis of that study, which included re-test in a subsample of women, we showed acceptable levels of reproducibility. Regarding a potential selection bias, we have evaluated possible differences between women with complete and missing data in terms of demographic and other confounding variables and we observed that women unable to provide this information were older and had lower educational background than those who did, being this difference similar in cases and controls. Another limitation is the high number of missing values in dietary variables. However, when we replicated the analyses introducing these variables in the models ([S1 Table](#pone.0164620.s001){ref-type="supplementary-material"} and [S2 Table](#pone.0164620.s002){ref-type="supplementary-material"}) results were not altered. It could be possible that unmeasured confounders affect our findings. Nevertheless, most established GC risk factors were controlled in the present study, with the exception of *Helicobacter pylori* infection. However, the infection caused by this bacterium is not a confounding factor in our study since, in agreement with the literature, no association was observed between this infection, measured by a serological assay, and the reproductive factors studied here (data not shown). Moreover, those unmeasured characteristics that could have a geographical distribution have been at least partly accounted for through the random effect province term included in our statistical analyses. Finally, we have small sample size to find statistically significant associations when evaluating certain subgroup associations for GC, such as the stratified analyses by anatomic subsite, histologic type or educational level.

Age at first birth was inversely associated with GC risk in the present study. In a previous meta-analysis no association with this variable was detected \[[@pone.0164620.ref011]\]. Nevertheless, some studies of this meta-analysis have found a borderline inverse association of age at first birth with GC in general \[[@pone.0164620.ref021]\], with all subsites and histological types of GC \[[@pone.0164620.ref022]\], with adenocarcinomas of the gastric cardia \[[@pone.0164620.ref023], [@pone.0164620.ref024]\], and with non-cardia gastric cancer in postmenopausal women\[[@pone.0164620.ref023]\].

Our results suggest a protective role of exogenous female hormones on gastric and colorectal cancer risk. Previous studies of oral contraceptives and GC have reported risk estimates from 0.79 to 2.50, with a pooled relative risk for ever use of 1.11 \[[@pone.0164620.ref011]\]. Only Frise et al detected a no significant decreased risk of gastric adenocarcinoma, more pronounced for the intestinal histologic subtype \[[@pone.0164620.ref025]\]. Nevertheless, the protective effect of hormone replacement therapy on GC risk has been reported in several studies \[[@pone.0164620.ref011], [@pone.0164620.ref026]\]. Evidence suggests that estrogens may offer protection against the development and progression of GC by acting on ERα and ERβ. The biological pathway is unclear, but several mechanisms have been suggested, such as the increased expression of trefoil factor genes, the inhibition of oncogenes' expression or decreasing bile acid concentration \[[@pone.0164620.ref027]\]. For this reason, it would be reasonable to think that parity might be associated with GC risk through these pathways. However, in consonance with our findings, the most recent meta-analysis of prospective cohort studies found no significant association \[[@pone.0164620.ref028]\].

With respect to CRC, three previous meta-analyses described an inverse association with oral contraceptives use, with summary relative risks of 0.81 \[[@pone.0164620.ref029]\] and 0.82 \[[@pone.0164620.ref030], [@pone.0164620.ref031]\]. Two of them detected no differences according to duration of use, although there were indications that the protection was stronger for more recent use \[[@pone.0164620.ref029], [@pone.0164620.ref030]\]. Meanwhile, Luan et al described a statistically significant nonlinear inverse association with duration of use \[[@pone.0164620.ref031]\]. Regarding hormone replacement therapy, two previous meta-analyses found an approximately 20% reduction in CRC risk among ever users \[[@pone.0164620.ref032], [@pone.0164620.ref033]\], similar for colon and rectal tumors \[[@pone.0164620.ref032]\]. This protective effect seems to be modulated through the ERβ, the predominant ER in the colon. During the tumorigenesis process, the ERβ expression in colonocytes is lost, and hormone replacement therapy exerts its effects through preventing this loss \[[@pone.0164620.ref008]\]. Increased local concentration of estrogens reduces the production of carcinogenic secondary bile acid, limits DNA damage and microsatellite instability and inhibits cell proliferation of colonic tumors \[[@pone.0164620.ref009]\].

When analyzing CRC risk, we have detected an interaction between months of first birth lactation and parity with educational level. Frise et al, in a study of reproductive factors and risk of gastric adenocarcinoma, also detected a statistically significant interaction between income level and parity \[[@pone.0164620.ref025]\]. With respect to lactation, previous studies have detected no association \[[@pone.0164620.ref034]--[@pone.0164620.ref036]\], except Lo et al, who found an inverse association with CRC risk \[[@pone.0164620.ref037]\]. Regarding parity, Guan et al, in a meta-analysis of prospective studies, found a 5% decreased CRC risk among parous versus nulliparous women, although they found no dose-response effect \[[@pone.0164620.ref038]\]. La Vecchia et al, in 6 out of 18 studies found significant protection by parity on CC or CRC risk \[[@pone.0164620.ref039]\]. When we additionally adjusted by other dietary CRC risk factors (such as calorie intake, red meat, processed meat, fruits, vegetables, and alcohol consumption) we also observed a significant interaction term with parity (P\<0.001) and almost significant with duration of lactation (P = 0.051). Since we do not find a clear biologic rationale for this result, it should be interpreted with caution in terms of prevention. It is possible that we were unable to completely adjust for these imprecisely measured factors, which may have led to some residual confounding. Other lifestyle conditions not yet identified could have influenced on these associations, as well as early-life conditions that could not be controlled for, given that these women grew up in a tough era marked by the Spanish civil war and long postwar period.

In brief, our results provide some support for the hypothesis that oral contraceptives and hormone replacement therapy decrease GC and CRC risk in women. We detected a decreased GC risk associated with advanced maternal age at first birth and a significant interaction of educational level with parity and breastfeeding. These findings are consistent with the exogenous hormone hypothesis. However, the role of endogenous hormones on GC and CRC risk remains to be elucidated, and should be explored taking into account socioeconomic factors and lifestyles closely related with reproductive patterns.
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